COVID Omicron News: FDA expands eligibility for remdesivir to anyone with mild to moderate symptoms

NEW YORK (WABC) — The Food and Drug Administration has extended the use of the antiviral remdesivir for treatment of mild to moderate COVID-19. The medication had received emergency use authorization in May 2020. Back then it was only for use in people hospitalized with severe COVID-19. In October of that year, it was approved … Read more